FDA Expands Incyte’s Opzelura Approval To Treat Atopic Dermatitis In Children

All NewsSeptember 19, 2025

FDA approves Incyte’s Opzelura cream for children aged two and older with atopic dermatitis, expanding its use beyond teens and adults.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent